In case you missed it: Jan. 24 to Jan. 28

It's been a busy week for the Contemporary OB/GYN® team. Here's a look at what you missed.

Estrogen and candida albicans

Research in the journal Cell Reports concludes that the discovery of a hormone-sensing pathway in Candida albicans, which enables the fungus to adapt to estrogen, could help explain gender biases linked to fungal infections and might provide an alternative approach to improving women's health.

Read more

Society for Maternal-Fetal Medicine Special Statement: COVID-19 research in pregnancy: progress and potential

The COVID-19 global pandemic has broad implications for obstetrical care and perinatal outcomes. As we approach the 2-year mark into an unprecedented international pandemic, this review presents the progress and opportunities for research related to COVID-19 and pregnancy.


Read more

Risk factors for preeclampsia

For preeclampsia, multifetal gestation was the most common high-risk factor among pregnant patients who gave birth in the United States in 2019.

Read now

Oral probiotics to prevent vulvovaginal infections in pregnant women

An oral probiotic formula for the secondary prevention of vulvovaginal infections in pregnant women neither colonized in the vagina nor reduced the rate of repeated vulvovaginal infection, according to a study in the American Journal of Gynecology & Obstetrics.

Read now